G. A. Popescu *, Cristina Popescu **
* Dr. Gabriel Adrian Popescu, medic primar Institutul de Boli Infecțioase Prof. Matei Balș, asist. univ. U.M.F. Carol Davila București
** Dr. Cristina Popescu, asist. univ. Clinica I Boli Infecțioase, Institutul de Boli Infecțioase Prof. Matei Balș, U.M.F. Carol Davila București
Abstract
Co-trimoscazole’s significance in reducing therapeutic aggresiveness of Wegener’s granulomatosis treatment
Wegener’s granulomatosis has an variable outcome, largely depending of clinical manifestations. Classical immunosupressive therapy is a doubtlessly option in renal forms of disease, Trimethoprim/sulfamethoxazole can be defined like a first line option for:
- non-renal clinical presentation
- maintaining regimen.